Tilray Brands (NASDAQ:TLRY) Stock Rating Lowered by Wall Street Zen

Wall Street Zen cut shares of Tilray Brands (NASDAQ:TLRYFree Report) to a strong sell rating in a research report sent to investors on Saturday morning.

Several other research firms also recently issued reports on TLRY. Piper Sandler decreased their price target on Tilray Brands from $2.00 to $1.00 and set a “neutral” rating for the company in a research note on Wednesday, April 9th. Roth Capital reiterated a “neutral” rating on shares of Tilray Brands in a research note on Monday, April 14th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Tilray Brands has an average rating of “Hold” and an average target price of $1.92.

Read Our Latest Analysis on TLRY

Tilray Brands Stock Performance

Shares of NASDAQ TLRY opened at $0.53 on Friday. The business’s 50-day moving average price is $0.43 and its two-hundred day moving average price is $0.73. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.62 and a quick ratio of 1.61. Tilray Brands has a one year low of $0.35 and a one year high of $2.15. The company has a market capitalization of $534.45 million, a P/E ratio of -0.51 and a beta of 1.82.

Tilray Brands (NASDAQ:TLRYGet Free Report) last released its quarterly earnings results on Tuesday, April 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.04) by ($0.06). The company had revenue of $185.78 million for the quarter, compared to the consensus estimate of $213.38 million. Tilray Brands had a negative return on equity of 7.40% and a negative net margin of 113.85%. Analysts anticipate that Tilray Brands will post -0.2 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Tilray Brands

Large investors have recently made changes to their positions in the business. Lido Advisors LLC acquired a new position in shares of Tilray Brands during the 4th quarter worth about $28,000. Dudley Capital Management LLC acquired a new position in shares of Tilray Brands during the 4th quarter worth about $29,000. Verdence Capital Advisors LLC acquired a new position in shares of Tilray Brands during the 4th quarter worth about $29,000. Cerity Partners LLC acquired a new position in shares of Tilray Brands during the 1st quarter worth about $31,000. Finally, Capital Management Associates Inc lifted its position in shares of Tilray Brands by 100.0% during the 1st quarter. Capital Management Associates Inc now owns 50,760 shares of the company’s stock worth $33,000 after purchasing an additional 25,380 shares during the last quarter. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Brands Company Profile

(Get Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

Read More

Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.